Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review

Keyphrases

• Treatment Choice 100%
• Alopecia Areata 100%
• Retrospective Review 100%
• Tofacitinib 100%
• Regrowth 40%
• Janus Kinase Inhibitors 40%
• Clinically Significant 20%
• Immune Response 20%
• Payment Method 20%
• Safety Outcomes 20%
• Retrospective Analysis 20%
• Hair Loss 20%
• Adverse Events 20%
• Scalp 20%
• Efficacy Outcomes 20%
• Serious Adverse Events 20%
• Off-label Use 20%
• Hair Diseases 20%
• Immune Treatment 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Alopecia Areata 100%
• Tofacitinib 100%
• Adverse Event 40%
• Minoxidil 40%
• Janus Kinase Inhibitor 40%
• Hair Loss 20%
• Hair Disease 20%
• Disease 20%
• Off-Label Use 20%